Lee Rodne has resigned as managing director and chief executive officer of Admedus, effective 30 June 2016. Mr Rodne has been a part of the company since the past 10 years.
Biotech company Admedus has initiated a capital raising comprising a placement and rights issue, with the hope of generating up to $28 million to fund ongoing development of various health care programs.
Biotech company Admedus has completed an oversubscribed $8 million share placement as it looks to push marketing for its CardioCel regenerative tissue product in Europe and the US.
Healthcare technology company Allied Healthcare Group will seek to raise $10 million as it looks to launch its CardioCel regenerative tissue patch in Europe.
